Amanta Healthcare announces a price band for his IPO. Check details

Amanta Healthcare has solved the price band for its upcoming IPO on RS 120–126 per share. The book construction number of 1 Crore shares shares will be opened for subscription on 1 September and will close on 3 September. The basis of the allocation is expected on 4 September, with a provisional list date of 8 September on both BSE and NSE.

Problem structure

The IPO is completely a new number of 1 Crore shares. According to the SEBI regulations, up to 50% of the net range will be reserved for qualified institutional buyers (QIBs), at least 35% for retail investors, and no less than 15% for non-institutional investors (NIIS).

Company background

Amanta Healthcare, founded in 1994, develops, produces and marks sterile liquid formulations and medical devices. The product portfolio comprises IV, fluids, dilution resources, ophthalmic solutions, respiratory care products, irrigation solutions and eye liters.

The company uses advanced aseptic blow-fill-seal (ABFS) and injection stretch bladder formation (ISBM) technologies for packaging. Amanta marks more than 45 generic products in India via a network of 320 distributors and stockists, while they also export brand products to 21 countries in Africa, Latin -America, the UK and other regions.

Financial performance

For FY25, the company reported the turnover of RS 276.09 Crore, slightly lower than RS 281.61 Crore in FY24. However, the profit after tax rose from 189% on an annual basis to RS 10.5 Crore, compared to RS 3.63 Crore in the previous tax.

Use of yields

The collected resources will be used for capital expenditures, including RS 70 Crore for setting up a new steriport production line in Hararyala, Gujarat and RS 30.13 Crore for a new SVP productive line at the same location. The remaining yields will be used for general business purposes. Beeline Capital Advisors is the book runner of the issue, while MUFG Intime India is the registrar.